Park C - Search Results

1

Identification of Copy Number Aberrations in Breast Cancer Subtypes Using Persistence Topology.

Arsuaga J, Borrman T, Cavalcante R, Gonzalez G, Park C. Arsuaga J, et al. Among authors: park c. Microarrays (Basel). 2015 Aug 12;4(3):339-69. doi: 10.3390/microarrays4030339. Microarrays (Basel). 2015. PMID: 27600228 Free PMC article.

2

Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI.

Nabavizadeh N, Klifa C, Newitt D, Lu Y, Chen YY, Hsu H, Fisher C, Tokayasu T, Olshen AB, Spellman P, Gray JW, Hylton N, Park CC. Nabavizadeh N, et al. Among authors: park cc. Integr Biol (Camb). 2011 Apr;3(4):490-6. doi: 10.1039/c0ib00089b. Epub 2011 Mar 18. Integr Biol (Camb). 2011. PMID: 21416100 Free PMC article.

3

Postmastectomy radiotherapy in patients with breast cancer.

Sethi R, Park C, Fowble B. Sethi R, et al. Among authors: park c. Lancet. 2014 Nov 22;384(9957):1845. doi: 10.1016/S0140-6736(14)62238-8. Epub 2014 Nov 21. Lancet. 2014. PMID: 25457912 No abstract available.

4

Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.

Acerbi I, Cassereau L, Dean I, Shi Q, Au A, Park C, Chen YY, Liphardt J, Hwang ES, Weaver VM. Acerbi I, et al. Among authors: park c. Integr Biol (Camb). 2015 Oct;7(10):1120-34. doi: 10.1039/c5ib00040h. Epub 2015 May 11. Integr Biol (Camb). 2015. PMID: 25959051 Free PMC article.

5

Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.

Campbell MR, Zhang H, Ziaee S, Ruiz-Saenz A, Gulizia N, Oeffinger J, Amin DN, Ahuja D, Moasser MM, Park CC. Campbell MR, et al. Among authors: park cc. Breast Cancer Res Treat. 2016 Feb;155(3):431-40. doi: 10.1007/s10549-016-3698-y. Epub 2016 Feb 9. Breast Cancer Res Treat. 2016. PMID: 26860947 Free PMC article.

6

Seminars in Radiation Oncology-Breast Cancer.

Park CC, Wright JL. Park CC, et al. Semin Radiat Oncol. 2022 Jul;32(3):187-188. doi: 10.1016/j.semradonc.2022.01.013. Semin Radiat Oncol. 2022. PMID: 35688516 No abstract available.

7

Increased beta1 integrin is associated with decreased survival in invasive breast cancer.

Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Yao ES, et al. Among authors: park c. Cancer Res. 2007 Jan 15;67(2):659-64. doi: 10.1158/0008-5472.CAN-06-2768. Cancer Res. 2007. PMID: 17234776

8

Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Park CC, et al. Among authors: park cj. Cancer Res. 2008 Jun 1;68(11):4398-405. doi: 10.1158/0008-5472.CAN-07-6390. Cancer Res. 2008. PMID: 18519702 Free PMC article.

9

Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.

Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM. Alvarado MD, et al. Among authors: park c. Breast Cancer Res Treat. 2014 Jan;143(1):135-40. doi: 10.1007/s10549-013-2782-9. Epub 2013 Nov 30. Breast Cancer Res Treat. 2014. PMID: 24292868

10

Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment.

Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. Park C, et al. Breast J. 2005 Jan-Feb;11(1):29-33. doi: 10.1111/j.1075-122X.2005.21527.x. Breast J. 2005. PMID: 15647075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,453 results

Search Page